Patent holdings for IPC class A61K 31/4525

Total number of patents in this class: 826

10-year publication summary

42
57
60
55
74
57
56
54
64
68
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10635
13
Glytech, LLC
18
12
Centre National de La Recherche Scientifique
10645
11
Clexio Biosciences Ltd.
104
11
Merck Sharp & Dohme LLC
3735
11
Vertex Pharmaceuticals Incorporated
1621
10
The Regents of the University of California
20245
9
Boehringer Ingelheim International GmbH
4644
9
Neurocrine Biosciences, Inc.
427
9
Southern Methodist University
118
9
Antecip Bioventures II LLC
345
8
Cipla Limited
467
8
Lixte Biotechnology, Inc.
63
8
Bristol-myers Squibb Company
4833
7
Takeda Pharmaceutical Company Limited
2719
7
Arena Pharmaceuticals, Inc.
359
7
Kyushu University, National University Corporation
1665
7
Sagimet Biosciences Inc.
26
7
The Trustees of Columbia University in the City of New York
3599
6
Alectos Therapeutics Inc.
48
6
Other owners 651